DETERMINANTS OF DIABETES MELLITUS AMONG ADULTS IN UZBEKISTAN

Mamatkulov T. T. & Umbetov F. M.


Annotatsiya

Diabetes mellitus is one of the most rapidly increasing non-communicable diseases worldwide and represents a major public health challenge in Central Asia, including Uzbekistan. The rise in prevalence is closely linked to lifestyle changes, urbanization, and the growing burden of metabolic risk factors. This study aimed to identify the prevalence and key determinants of diabetes mellitus among adults in Uzbekistan. The overall prevalence of diabetes mellitus was 13.6%, while prediabetes was 7.9%. Multivariate analysis revealed that age over 40 years (AOR = 2.84; 95% CI: 1.65–4.92), obesity (AOR = 3.12; 95% CI: 1.78–5.47), physical inactivity (AOR = 2.21; 95% CI: 1.29–3.78), frequent fried food consumption (AOR = 1.96; 95% CI: 1.12–3.41), and chronic stress (AOR = 2.37; 95% CI: 1.34–4.19) were significantly associated with diabetes mellitus. Diabetes mellitus in Uzbekistan is strongly associated with modifiable lifestyle factors and non-modifiable demographic characteristics. Strengthening preventive strategies focused on healthy diet, physical activity, stress management, and early screening is essential to reduce the growing burden of the disease.


Adabiyotlar

  1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 10th Edition. Brussels: IDF; 2021.
  2. World Health Organization. Global Report on Diabetes. Geneva: WHO; 2016.
  3. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates. Diabetes Research and Clinical Practice. 2019;157:107843.
  4. Khan MA, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes – global burden. World Journal of Diabetes. 2020;11(4):130–142.
  5. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates. Diabetes Research and Clinical Practice. 2018;138:271–281.
  6. Zheng Y, Ley SH, Hu FB. Global aetiology of type 2 diabetes. Nature Reviews Endocrinology. 2018;14(2):88–98.
  7. Magliano DJ, Boyko EJ. Diabetes complications and burden. Lancet Diabetes Endocrinology. 2021;9(6):325–340.
  8. Emerging Risk Factors Collaboration. Body mass index and diabetes risk. The Lancet. 2014;383(9924):970–983.
  9. Hu FB. Globalization of diabetes. Diabetes Care. 2011;34(6):1249–1257.
  10. Powers AC, Niswender KD, Evans-Molina C. Diabetes mellitus: pathophysiology and management. Endocrine Reviews. 2020;41(4):bnaa012.
  11. Hoogeveen E. K. The epidemiology of diabetic kidney disease //Kidney and Dialysis. – 2022. – Т. 2. – №. 3. – С. 433-442.
  12. Zhang K. et al. Global, regional, and national epidemiology of diabetes in children from 1990 to 2019 //JAMA pediatrics. – 2023. – Т. 177. – №. 8. – С. 837-846.
  13. Li Y. Y. et al. Global epidemiology of diabetes and prediabetes in lean or non-obese patients with NAFLD: a systematic review and meta-analysis //Annals of Medicine. – 2026. – Т. 58. – №. 1. – С. 2602995.
  14. Zhou J. et al. DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study //Diabetologia. – 2025. – Т. 68. – №. 7. – С. 1423-1439.